Global Sodium Ascorbate Excipient Market Size, Share, and COVID-19 Impact Analysis, By End-Use (Pharmaceuticals, Food & Beverages, and Others), By Sales Channel (Direct Sale and Indirect Sale), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Sodium Ascorbate Excipient Market Size Insights Forecasts to 2035

• The Global Sodium Ascorbate Excipient Market Size Was Estimated at USD 158.41 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.91% from 2025 to 2035
• The Worldwide Sodium Ascorbate Excipient Market Size is Expected to Reach USD 405.27 Million by 2035
• North America is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Spherical Insights and Consulting, The Global Sodium Ascorbate Excipient Market Size was worth around USD 158.41 Million in 2024 and is predicted to Grow to around USD 405.27 Million by 2035 with a compound annual growth rate (CAGR) of 8.91% from 2025 to 2035. The sodium ascorbate excipient market globally is expanding due to a rise in demand for stable inactive forms of vitamin C in pharmaceutical application substances and food and cosmetic application substances featuring clean label forms of antioxidants, which are becoming more popular.

Market Overview

The international sodium ascorbate excipients market involves sodium ascorbate, a compound with good chemical stability, solubility in water, and a lack of acidity, and is an essential component in various pharmaceutical products as a vitamin C antioxidant agent. It finds use in tablets, capsules, synips, and injectables to ensure shelf life and efficacy of drug substances against oxidation reactions The factors driving the global sodium ascorbate excipients market are demand for safer excipients, increased general knowledge and awareness of the importance and health implications of vitamin C, and growth in the international pharmaceutical and international nutraceutical industries There is an opportunity in new and varied drug delivery systems, clean label development, and untapped markets with increase in health expenditures The dominant players in the pharmaceutical excipients and health-focused markets include DSM-Firmenich, BASF, Northeast Pharmaceutical Group, CSPC Pharmaceutical Group, Hebei Welcome Pharmaceutical, and Zhejiang Medicine. In June 2025, the European Commission introduced Regulation 2025/1150, amending Regulation (EC) No 1333/2008 to include sodium ascorbate (E301) as a carry-over antioxidant in microencapsulated vitamin A intended to be used in infant formula and follow-on formula. The European Food Safety Authority confirmed the safe use of EFSA, thus guaranteeing the stability of vitamin A, preventing the degradation of the compound, and permitting.

Report Coverage

This research report categorizes the sodium ascorbate excipient market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the sodium ascorbate excipient market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the sodium ascorbate excipient market. 

Driving Factors

The primary drivers of the global sodium ascorbate excipient market are the increased demand for antioxidants in pharmaceuticals in order to enhance the stability and bioavailability of drugs, especially biologics. The rise of clean label is boosting demand in the pharmaceutical and biotechnology sectors. The rising health-conscious lifestyle is another driver of the sale of health supplements and foods, thus boosting demand. The advancements in technology with regard to the use of sodium ascorbate excipients in pharmaceuticals enhance efficiency and purity, thus reducing costs and making it a popular choice. It can be utilized in both pharmaceutical and non-pharmaceutical products.

Restraining Factors

Some of the main restraining factors affecting the global sodium ascorbate excipient market are the volatile supply chain scenario, fluctuating prices of raw materials such as corn or sugar used to produce sodium ascorbate, and stringent and diverse regulatory scenarios pertaining to food purity across various countries. Another factor is its sensitivity to light, heat, or oxygen, along with the presence of alternatives such as antioxidants.

Market Segmentation

The sodium ascorbate excipient market share is classified into end-use and sales channel.  

• The pharmaceuticals segment dominated the market in 2024, approximately 38% and is projected to grow at a substantial CAGR during the forecast period.

Based on the end use, the sodium ascorbate excipient market is divided into pharmaceuticals, food & beverages, and others. Among these, the pharmaceuticals segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The pharmaceutical industry has been the dominant segment, attributed to the primary usage of the excipient in the pharmaceutical industry as a stabilizer as well as an antioxidant in the formulated drugs meant for human consumption. Enhanced usage in vitamin C-enriched drugs, solutions for injections, as well as nutraceuticals, has led to a sizeable increase in the share held by this excipient in the industry while the healthcare expenditure is hiking worldwide.

• The direct sale segment accounted for the highest market revenue in 2024, approximately 45% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the sales channel, the sodium ascorbate excipient market is divided into direct sale and indirect sale. Among these, the direct sale segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The direct sale segment generated the highest market growth for the sodium ascorbate excipient market due to cordial relationships between manufacturers and consumers and better-quality assurance for direct sales. It is observed that most pharma, nutraceuticals, and food formulations are purchased through the direct sales channel to guarantee quality and quality assurances with efficient delivery of services for the lowest costs.

Regional Segment Analysis of the Sodium Ascorbate Excipient Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is anticipated to hold the largest share of the sodium ascorbate excipient market over the predicted timeframe.

Asia Pacific is anticipated to hold the largest share of the sodium ascorbate excipient market over the predicted timeframe. Asia Pacific is expected to account for a 38% share in the sodium ascorbate excipient market, owing to a high growth rate in pharmaceutical, nutraceutical, and fortified foods, increases in healthcare expenses, and improving knowledge about the usage of vitamin C. Countries such as China, India, and Japan have high demands for excipients, with support from robust manufacturing facilities, an increase in the generic medicine business, and various government initiatives regarding nutritional supplements. In addition, the Singapore Food Agency, in an announcement in August 2025, noted that various regulations regarding functional ingredients would be introduced based on the late-2024 roundtables regarding regulations.

North America is expected to grow at a rapid CAGR in the sodium ascorbate excipient market during the forecast period. North America is expected to have a 30% market share will rise at a high growth rate in the sodium ascorbate excipient market, driven by increasing demand from nutraceuticals, fortified foods, as well as pharmaceutical ingredients, with the USA and Canada at its helm, owing to a rise in health awareness, fortified food consumption, as well as a high rate of supplement usage in these countries, along with high standards in food as well as pharmaceutical formulation industry infrastructure, in combination with research as well as government support towards fortified food projects.

The European region is witnessing an expansion in the use of the excipient in the form of sodium ascorbate, fuelled by a growing demand for the compound in pharmaceuticals, functional foods, and dietary supplements in Germany, France, and the United Kingdom. Government approvals for the addition of antioxidants to foods also aid in propelling the business forward.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the sodium ascorbate excipient market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• DSM Firmenich N.V.
• BASF SE
• CSPC Pharmaceutical Group
• Northeast Pharmaceutical Group
• Hebei Welcome Pharmaceutical
• Zhejiang Medicine
• Merck KGaA
• Evonik Industries
• DuPont
• Colorcon, Inc.
• JRS PHARMA
• Spectrum Chemical Mfg. Corp
• Foodchem International Corporation
• Vantage Specialty Chemicals, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In December 2025, the U.S. vitamin and supplement industry, valued at $37.2 billion in 2022, highlights growing consumer interest in preventive healthcare. The market relies on a complex network of manufacturers, suppliers, and distributors, emphasizing stringent quality controls, specialized facilities, and global raw material supply chains to deliver safe, effective products.

• In October 2025, Jiangxi Yongtai Technology Co. (China) launched a new line of eco-friendly sodium ascorbate products, highlighting sustainable manufacturing and applications in food and pharmaceutical excipients. The initiative targets eco-conscious markets and aligns with growing global sustainability trends in the excipient and functional ingredient industry.

• In September 2024, Merck became the first company in the industry to achieve EXCiPACT cGMP certification for Pharmaceutical Auxiliary Materials at its global Cell Culture Media production sites. The certification, a recognized standard for non-sterile excipient manufacturing, underscores Merck’s commitment to quality, compliance, and industry leadership.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the sodium ascorbate excipient market based on the below-mentioned segments: 

Global Sodium Ascorbate Excipient Market, By End-Use

• Pharmaceuticals
• Food & Beverages
• Others

Global Sodium Ascorbate Excipient Market, By Sales Channel

• Direct Sale
• Indirect Sale

Global Sodium Ascorbate Excipient Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa